Clinical Trial Update: An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating ezogabine/retigabine added to existing anti-epileptic drugs on urinary voiding function in adults with partial onset seizure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Ezogabine/Retigabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 4 | Status: TERMINATED | Results posted: 2017-09-26